What is a major safety concern when combining multiple OTC products that contain the same active ingredient?

• A. Potential overdose from duplicative dosing
• B. Increased absorption
• C. Reduced efficacy
• D. Unrelated adverse effects

Answer: (A)

When multiple OTC products share the same active ingredient, the main safety risk is duplicative dosing. Each product has a recommended maximum daily amount, and using more than one product with the same ingredient can push your total intake beyond that safe limit, increasing the chance of overdose and serious adverse effects. A clear example is acetaminophen, which appears in many pain and cold medicines; exceeding the total daily amount can cause liver injury. To prevent this, always check labels for active ingredients, add up the total amount you’re taking across all products, and avoid using two products that contain the same ingredient unless a clinician advises it. If unsure, ask a pharmacist.

The other possibilities aren’t the primary safety concern here. Increased absorption isn’t the usual issue when stacking OTC products with the same API, reduced efficacy isn’t the typical risk pattern, and unrelated adverse effects don’t capture the common danger of overdose from duplicative dosing.